| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| CA(R) | 174 | 49.0% | -3.86 | 12 | 50.0% |
| MB(R) | 174 | 49.0% | -3.86 | 12 | 50.0% |
| CentralBrain-unspecified | 7 | 2.0% | -inf | 0 | 0.0% |
| upstream partner | # | NT | conns KC | % In | CV |
|---|---|---|---|---|---|
| VA6_adPN (R) | 1 | ACh | 43 | 25.0% | 0.0 |
| VL2a_adPN (R) | 1 | ACh | 23 | 13.4% | 0.0 |
| VA7l_adPN (R) | 1 | ACh | 22 | 12.8% | 0.0 |
| VP1d+VP4_l2PN1 (R) | 1 | ACh | 20 | 11.6% | 0.0 |
| APL (R) | 1 | GABA | 13 | 7.6% | 0.0 |
| MB-C1 (R) | 3 | GABA | 12 | 7.0% | 0.7 |
| VA7m_lPN (R) | 1 | ACh | 11 | 6.4% | 0.0 |
| DC2_adPN (R) | 1 | ACh | 10 | 5.8% | 0.0 |
| KCab-s (R) | 5 | ACh | 6 | 3.5% | 0.3 |
| KCg-m (R) | 5 | ACh | 5 | 2.9% | 0.0 |
| KCab-m (R) | 1 | ACh | 2 | 1.2% | 0.0 |
| KCa'b'-m (R) | 2 | ACh | 2 | 1.2% | 0.0 |
| KCa'b'-ap2 (R) | 1 | ACh | 1 | 0.6% | 0.0 |
| VL2p_adPN (R) | 1 | ACh | 1 | 0.6% | 0.0 |
| PPL202 (R) | 1 | DA | 1 | 0.6% | 0.0 |
| downstream partner | # | NT | conns KC | % Out | CV |
|---|---|---|---|---|---|
| APL (R) | 1 | GABA | 9 | 34.6% | 0.0 |
| KCg-m (R) | 4 | ACh | 5 | 19.2% | 0.3 |
| MBON22 (R) | 1 | ACh | 3 | 11.5% | 0.0 |
| KCab-s (R) | 2 | ACh | 2 | 7.7% | 0.0 |
| KCa'b'-ap2 (R) | 2 | ACh | 2 | 7.7% | 0.0 |
| KCab-c (R) | 1 | ACh | 1 | 3.8% | 0.0 |
| KCa'b'-m (R) | 1 | ACh | 1 | 3.8% | 0.0 |
| VM5d_adPN (R) | 1 | ACh | 1 | 3.8% | 0.0 |
| MB-C1 (R) | 1 | GABA | 1 | 3.8% | 0.0 |
| VA4_lPN (R) | 1 | ACh | 1 | 3.8% | 0.0 |
